DOI:
10.1055/s-00000002
Aktuelle Dermatologie
LinksClose Window
References
Blauvelt A, Kempers S, Forman S. et al.
irbanibulin Ointment 1%, a Novel Inhibitor of Tubulin Polymerization and Src Kinase Signaling, for the Treatment of Actinic Keratosis (AK): Results from Two Pivotal Phase III Studies.
SKIN The Journal of Cutaneous Medicine 2020;
4: S63
DOI: 10.25251/skin.4.supp.62. 2020.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.